MiniMed Group MMED
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 34th percentile, 5-year average -13.9x
Above its usual level · 61st percentile, 5-year average 1.3x
#2260 of 5331 stocks by PB (1 = cheapest)
Around its usual level · 56th percentile, 5-year average 1.5x
#2231 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.40 | – | 1.26 | 61% (pricier than usual) | #2260 of 5331 (1 = cheapest) |
| PE | -15.96 | 36.57 | -13.93 | 34% (cheaper than usual) | – |
| PS | 1.57 | 1.46 | 1.47 | 56% (pricier than usual) | #2231 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on MMED.
Sign in to join the discussion.